HTA Review Reference Committee

The HTA Review Reference Committee is responsible for overseeing the Health Technology Assessment (HTA) Policy and Methods Review.

Role

The HTA Review Reference Committee will oversee the Health Technology Assessment (HTA) Policy and Methods Review.

The HTA Review Reference Committee will:

  • agree the terms of reference for the HTA Review
  • agree the expert in HTA to support the HTA Review
  • oversee public consultations and considering submissions to the HTA Review
  • oversee the analysis undertaken by the expert in HTA
  • prepare a final review report and recommendations.

Members

MemberRole on the Reference Committee
Adjunct Professor Debora Picone AOIndependent Chair
Ms Ann SinglePatient Representative
Dr Dawn Casey PSMPatient Representative
Professor Andrew WilsonChair of the Pharmaceutical Benefits Advisory Committee (PBAC)
Professor Andrew Roberts AMClinical/Scientific Representative
Ms Elizabeth de SomerMember nominated by Medicines Australia
Ms Adriana Platona PSMGovernment Nominee

Meeting agendas

The committee held meetings as needed to meet the 31 December 2023 review deadline.

Communiques

Other documents

Contact

HTA Review Secretariat

Contact for the Health Technology Assessment Review
Date last updated: